Timber Pharmaceuticals’ Chapter 11 and Asset Sale to Leo Pharma

Laura Testa
Tagged:

Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction.Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now